Evidence map›Paper›PMID 28691036›Full record

ArticleBioMed research international2017

Detection of Secondary Causes and Coexisting Diseases in Hypertensive Patients: OSA and PA Are the Common Causes Associated with Hypertension.

Lei Wang, Nanfang Li, Xiaoguang Yao, Guijuan Chang, Delian Zhang, Mulalibieke Heizhati, Menghui Wang, Qin Luo, Jianqiong Kong

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Targeted Metabolomics as a Tool in Discriminating Endocrine From Primary Hypertension.The Journal of clinical endocrinology and metabolism · 2021
    Article
  10. Article
  11. Review
  12. Obstructive sleep apnea, hypertension, resistant hypertension and cardiovascular disease.Sleep medicine and disorders : international journal · 2020
    Article
  13. Article
  14. Pheochromocytomas and Hypertension.Current hypertension reports · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Lei WangHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Nanfang LiHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.ORCID 0000-0002-3984-6084
Xiaoguang YaoHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Guijuan ChangHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Delian ZhangHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Mulalibieke HeizhatiHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Menghui WangHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Qin LuoHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
Jianqiong KongHypertension Institute of Xinjiang, Hypertension Center of the People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China.
People's Hospital of Xinjiang Uygur Autonomous Region · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince the control rate of blood pressure is lower in mainland China, the aim of this study is to investigate the proportion of secondary causes and coexisting diseases of hypertension in hypertensive patients.

methodsData on consecutive patients with hypertension who visited the Hypertension Center. Diseases were detected using an established strict screening protocol.

resultsDetection rate of secondary causes and coexisting diseases of hypertension was 39.5% among 3003 hypertensive patients. Obstructive sleep apnea (OSA) was the most common, accounting for 24.7% of patients, followed by primary aldosteronism (PA) (5.8%) and PA + OSA (4.9%). Endocrine hypertension accounted for 12.1% of patients, including 10.7% of patients with PA, 1.1% with hypothyroidism, 0.1% with pheochromocytoma, 0.1% with Cushing's syndrome, and 0.1% with hyperthyroidism, respectively. Those who smoke, those who are obese, and those who have diabetes accounted for 31.3%, 27.5%, and 16.6% of total patients, respectively. There were overlapping conditions in secondary causes and coexisting diseases of hypertension. OSA was the most common in each age- and BMI-stratified group.

conclusionFindings from the current study suggest an increasing frequency of secondary forms of hypertension, highlighting the burden of OSA and PA in hypertensive patients.

Indexed as

Body Mass IndexFemaleHumansHyperaldosteronismHypertensionMaleMiddle AgedSleep Apnea, Obstructive

Identifiers

PMID28691036
PMCPMC5485286
OpenAlexW2625695611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.